BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28410580)

  • 1. Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome.
    Compare D; Rocco A; Coccoli P; Angrisani D; Sgamato C; Iovine B; Salvatore U; Nardone G
    BMC Gastroenterol; 2017 Apr; 17(1):53. PubMed ID: 28410580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal administration of Lactobacillus casei DG modifies flora composition and Toll-like receptor expression in colonic mucosa of patients with mild ulcerative colitis.
    D'Incà R; Barollo M; Scarpa M; Grillo AR; Brun P; Vettorato MG; Castagliuolo I; Sturniolo GC
    Dig Dis Sci; 2011 Apr; 56(4):1178-87. PubMed ID: 20737210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine Response after Stimulation with Key Commensal Bacteria Differ in Post-Infectious Irritable Bowel Syndrome (PI-IBS) Patients Compared to Healthy Controls.
    Sundin J; Rangel I; Repsilber D; Brummer RJ
    PLoS One; 2015; 10(9):e0134836. PubMed ID: 26366730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mild moxibustion on intestinal microbiota and NLRP6 inflammasome signaling in rats with post-inflammatory irritable bowel syndrome.
    Bao CH; Wang CY; Li GN; Yan YL; Wang D; Jin XM; Wu LY; Liu HR; Wang XM; Shi Z; Wu HG
    World J Gastroenterol; 2019 Aug; 25(32):4696-4714. PubMed ID: 31528095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Probiotics may reduce inflammation by enhancing peroxisome proliferator activated receptor gamma activation in HT-29 cells].
    Eun CS; Han DS; Lee SH; Jeon YC; Sohn JH; Kim YS; Lee J
    Korean J Gastroenterol; 2007 Mar; 49(3):139-46. PubMed ID: 18172341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imbalanced shift of cytokine expression between T helper 1 and T helper 2 (Th1/Th2) in intestinal mucosa of patients with post-infectious irritable bowel syndrome.
    Chen J; Zhang Y; Deng Z
    BMC Gastroenterol; 2012 Jul; 12():91. PubMed ID: 22816602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype.
    Belmonte L; Beutheu Youmba S; Bertiaux-Vandaële N; Antonietti M; Lecleire S; Zalar A; Gourcerol G; Leroi AM; Déchelotte P; Coëffier M; Ducrotté P
    PLoS One; 2012; 7(8):e42777. PubMed ID: 23028414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multispecies probiotic protects gut barrier function in experimental models.
    Nébot-Vivinus M; Harkat C; Bzioueche H; Cartier C; Plichon-Dainese R; Moussa L; Eutamene H; Pishvaie D; Holowacz S; Seyrig C; Piche T; Theodorou V
    World J Gastroenterol; 2014 Jun; 20(22):6832-43. PubMed ID: 24944474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global Cytokine Profiles and Association With Clinical Characteristics in Patients With Irritable Bowel Syndrome.
    Bennet SM; Polster A; Törnblom H; Isaksson S; Capronnier S; Tessier A; Le Nevé B; Simrén M; Öhman L
    Am J Gastroenterol; 2016 Aug; 111(8):1165-76. PubMed ID: 27272011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactobacillus casei prevents the development of dextran sulphate sodium-induced colitis in Toll-like receptor 4 mutant mice.
    Chung YW; Choi JH; Oh TY; Eun CS; Han DS
    Clin Exp Immunol; 2008 Jan; 151(1):182-9. PubMed ID: 18005362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced interstitial cells of Cajal and increased intraepithelial lymphocytes are associated with development of small intestinal bacterial overgrowth in post-infectious IBS mouse model.
    Chen B; Zhu S; Du L; He H; Kim JJ; Dai N
    Scand J Gastroenterol; 2017 Oct; 52(10):1065-1071. PubMed ID: 28679338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Ileal Immunoglobulin A Production and Immunoglobulin A-Coated Bacteria in Diarrhea-Predominant Irritable Bowel Syndrome.
    Liu Y; Yuan X; Li L; Lin L; Zuo X; Cong Y; Li Y
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00146. PubMed ID: 32352710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herbal prescription Chang'an II repairs intestinal mucosal barrier in rats with post-inflammation irritable bowel syndrome.
    Wang FY; Su M; Zheng YQ; Wang XG; Kang N; Chen T; Zhu EL; Bian ZX; Tang XD
    Acta Pharmacol Sin; 2015 Jun; 36(6):708-15. PubMed ID: 25960135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of moxibustion on colonic low-grade inflammatory response in rats with diarrhea-predominant irritable bowel syndrome based on mast cell degranulation.
    Fang M; Chu H; Song X; Ruan J; Zou L; Li K; Liao L; Ma W; Han X; Zhu J; Wang Z; Fang Y
    Zhongguo Zhen Jiu; 2024 Mar; 44(3):283-294. PubMed ID: 38467503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of Rifaximin in post-infectious irritable bowel syndrome mouse model beyond gut microbiota.
    Jin Y; Ren X; Li G; Li Y; Zhang L; Wang H; Qian W; Hou X
    J Gastroenterol Hepatol; 2018 Feb; 33(2):443-452. PubMed ID: 28573746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting.
    De Silva AP; Nandasiri SD; Hewavisenthi J; Manamperi A; Ariyasinghe MP; Dassanayake AS; Jewell DP; de Silva HJ
    Scand J Gastroenterol; 2012 Jun; 47(6):619-24. PubMed ID: 22486731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of
    Cao YN; Feng LJ; Liu YY; Jiang K; Zhang MJ; Gu YX; Wang BM; Gao J; Wang ZL; Wang YM
    World J Gastroenterol; 2018 Jan; 24(3):338-350. PubMed ID: 29391756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of probiotic supplementation on post-infectious irritable bowel syndrome in rodent model.
    Hong KB; Seo H; Lee JS; Park Y
    BMC Complement Altern Med; 2019 Jul; 19(1):195. PubMed ID: 31366385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ileocolonic Histopathological and Microbial Alterations in the Irritable Bowel Syndrome: A Nested Community Case-Control Study.
    Talley NJ; Alexander JL; Walker MM; Jones MP; Hugerth LW; Engstrand L; Agréus L; Powell N; Andreasson A
    Clin Transl Gastroenterol; 2020 Dec; 12(1):e00296. PubMed ID: 33464728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum and colonic mucosal immune markers in irritable bowel syndrome.
    Chang L; Adeyemo M; Karagiannides I; Videlock EJ; Bowe C; Shih W; Presson AP; Yuan PQ; Cortina G; Gong H; Singh S; Licudine A; Mayer M; Tache Y; Pothoulakis C; Mayer EA
    Am J Gastroenterol; 2012 Feb; 107(2):262-72. PubMed ID: 22158028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.